Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million

by Shana Cristoferi | Sep 11, 2019 | News

Read original news release here — Transaction continues to advance Mallinckrodt’s strategic focus on branded biopharmaceuticals by monetizing a non-core business — — H.I.G. Capital to support BioVectra leadership and its attractive growth plan...

NEWS RELEASE: BioVectra Inc. announces a $144.6 million expansion project, including a $37.5 million contribution through the Government of Canada’s Strategic Innovation Fund

by Shana Cristoferi | Mar 4, 2019 | BioVectra, News

BioVectra Inc. announces a $144.6 million expansion project, including a $37.5 million contribution through the Government of Canada’s Strategic Innovation Fund — Prime Minister Justin Trudeau visits BioVectra to announce Government of Canada investment in...

Canadian Biotech Industry Recognizes Top Performers During Global Biotech Week

by administrator | Sep 26, 2018 | BioVectra, News

Mussels, potatoes, ‘Anne of Green Gables,’ and now microbial fermentation

by administrator | Jul 10, 2018 | BioVectra, News

Arriving for a visit to BioVectra, a Canadian contract development and manufacturing organization (CDMO), one is reminded that pharmaceutical services companies are an idiosyncratic lot. Most are small- to medium-sized firms whose offerings vary as widely as do their...

News Release ACOA: Windsor Expansion Helps BioVectra Meet Global Market Demand

by administrator | Apr 12, 2018 | Atlantic Canada Opportunities Agency (ACOA), BioVectra, News

Extensive facility renovation, new equipment, assists life sciences firm in creating jobs, growing regional economy April 12, 2018 – Windsor, NS – Atlantic Canada Opportunities Agency Canada is a country of innovators. Curiosity, creativity and a collaborative spirit...